| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |